Skip to main content
Fig. 4 | BMC Complementary Medicine and Therapies

Fig. 4

From: Gut microbiota combined with fecal metabolomics reveals the effects of FuFang Runzaoling on the microbial and metabolic profiles in NOD mouse model of Sjögren’s syndrome

Fig. 4

Assessments of differences in gut microbiota. PCoA of the gut microbiota in mice after FRZ treatment for 10 weeks (A) and the taxonomic distributions of bacteria (Top 15) at the phylum (B) and genus C. Scatter plots of significantly altered bacterial taxa, including family (D) and genus E. * P < 0.05 and ** P < 0.01 according to ANOVA (n = 8)

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us